Research Overview: Ultima-Sus 500 Ultima Pharmaceuticals
Ultima-Sus 500 is a multi-ester testosterone formulation developed for sustained-release hormone investigations. This pharmaceutical blend combines testosterone propionate, phenylpropionate, isocaproate, and decanoate esters to evaluate prolonged androgenic activity patterns in laboratory settings. Researchers at Stroid UK Shop utilise this compound to examine how different ester chain lengths affect hormone release kinetics and tissue distribution profiles in controlled studies. The formulation provides a valuable tool for investigating the pharmacokinetic differences between rapid-acting and long-acting testosterone derivatives in preclinical models.
Laboratory Applications
Research teams investigate Ultima-Sus 500 to study androgen receptor binding affinity, protein synthesis modulation, and endocrine system feedback mechanisms. The compound serves as a reference standard for comparing how various ester combinations influence bioavailability and clearance rates in tissue samples. Scientists examine its effects on gene expression patterns related to muscle protein synthesis, bone mineralisation pathways, and nitrogen retention mechanisms. Studies focus on understanding how sustained testosterone exposure affects cellular signalling cascades compared to single-ester formulations. Researchers also analyse this blend alongside compounds from our steroid injection collection to evaluate comparative androgenic potencies and metabolic pathway interactions in laboratory environments.
Technical Specifications
| Parameter | Specification |
|---|---|
| Total Concentration | 500 mg/mL |
| Ester Composition | Multi-ester testosterone blend |
| Molecular Formula | Verify with supplier |
| Storage Temperature | Room temperature, protect from light |
| Solvent System | Oil-based injection vehicle |
| Research Grade | Laboratory standard |
This testosterone formulation enables comprehensive studies of how ester chain modifications influence pharmacokinetic profiles and tissue-specific activity patterns. Research applications extend to examining interactions with other hormone modulators available through our SARM research compounds and peptide research collection for understanding complex endocrine pathway relationships.
Regulatory Compliance
Ultima-Sus 500 is supplied exclusively for in-vitro research and analytical reference applications. This product is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and ensure compliance with institutional research guidelines when handling this material.
